Skip to main content
Top
Published in: Clinical Rheumatology 4/2004

01-08-2004 | Original Article

Continuity of cytokine activation in patients with familial Mediterranean fever

Authors: Sait Bagci, Bulent Toy, Ahmet Tuzun, Yuksel Ates, Murat Aslan, Ali Inal, Mustafa Gulsen, Necmettin Karaeren, Kemal Dagalp

Published in: Clinical Rheumatology | Issue 4/2004

Login to get access

Abstract

Familial Mediterranean fever (FMF) is a recessively inherited inflammatory disorder, characterized by recurrent attacks of fever and polyserositis. It has been considered that miscellaneous cytokines take part in the pathogenesis of the disease. The aim of this study was to investigate serum levels of soluble interleukin-2 receptor (sIL-2R), interleukin-6 (IL-6), and interleukin-10 (IL-10) in patients with FMF. The study included 42 patients with FMF (3 females, 39 males, mean age: 24.43 years) and 20 healthy volunteers as the control group (18 males, 2 females, mean age: 23.2 years). The patients were chosen according to Eliakim criteria. After recording their history and performing an examination, leukocyte counts, erythrocyte sedimentation rates (ESR), C-reactive protein (CRP), fibrinogen, sIL-2R, IL-6, and IL-10 levels were measured before and during attacks. A significant increase was found in leukocyte (p<0.001), ESR (p<0.001), CRP (p<0.001), and fibrinogen (p<0.001) levels of the patient group in the attack period compared to those in the quiescent state. sIL-2R (p=0.019) and IL-6 (p<0.001) levels showed significant increases during attacks compared to the levels before an attack. There was no significant difference between IL-10 levels. The levels of the three cytokines were significantly high both before and during the attacks compared to the control group. As a result, the elevation of sIL-2R and IL-6 levels both before and during the attacks compared to control group suggests the existence of continuous cytokine activation in the patients. No significant increase in the IL-10 levels in spite of the significant rise of sIL-2R and IL-6 during attacks supports the notion of inflammation and also reveals that compensation by anti-inflammatory IL-10 does not seem to occur.
Literature
1.
go back to reference Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253PubMed Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43:227–253PubMed
2.
go back to reference Schattner A, Lachmi M, Livneh A, Pras M, Hahn T (1991) Tumor necrosis factor in familial Mediterranean fever. Am J Med 90:434–438PubMed Schattner A, Lachmi M, Livneh A, Pras M, Hahn T (1991) Tumor necrosis factor in familial Mediterranean fever. Am J Med 90:434–438PubMed
3.
go back to reference Erken E, Günesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855PubMed Erken E, Günesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855PubMed
4.
go back to reference Ozyılkan E, Simsek H, Telatar H (1992) Tumor necrosis factor in familial Mediterranean fever. Am J Med 92:579–580PubMed Ozyılkan E, Simsek H, Telatar H (1992) Tumor necrosis factor in familial Mediterranean fever. Am J Med 92:579–580PubMed
5.
go back to reference Rozenbaum M, Katz R, Rozner I, Pollack S (1992) Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 19:416–418PubMed Rozenbaum M, Katz R, Rozner I, Pollack S (1992) Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 19:416–418PubMed
6.
go back to reference Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I (2002) Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 3:43–45CrossRefPubMed Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I (2002) Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun 3:43–45CrossRefPubMed
7.
go back to reference Mege JL, Dilşen N, Sanguedolce V, et al. (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549PubMed Mege JL, Dilşen N, Sanguedolce V, et al. (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549PubMed
8.
9.
go back to reference Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190PubMed Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165–190PubMed
10.
go back to reference Eliakim M, Levy M, Ehrenfeld M (1981) Recurrent polyserositis (familial Mediterranean fever, periodic disease). Elsevier/North-Holland Biomedical Press, Amsterdam Eliakim M, Levy M, Ehrenfeld M (1981) Recurrent polyserositis (familial Mediterranean fever, periodic disease). Elsevier/North-Holland Biomedical Press, Amsterdam
11.
go back to reference International Committee for Standardization in Haematology (1988) Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 41:1203–1212PubMed International Committee for Standardization in Haematology (1988) Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 41:1203–1212PubMed
12.
go back to reference Whicher JT, Bell AM, Southall PJ (1981) Measurements in clinical management. Diagn Med 4:62–80 Whicher JT, Bell AM, Southall PJ (1981) Measurements in clinical management. Diagn Med 4:62–80
13.
go back to reference Ilfeld D, Weil S, Kuperman O (1981) Immunoregulatory abnormalities in familial Mediterranean fever. Clin Immunol Immunopathol 18:261–267CrossRefPubMed Ilfeld D, Weil S, Kuperman O (1981) Immunoregulatory abnormalities in familial Mediterranean fever. Clin Immunol Immunopathol 18:261–267CrossRefPubMed
14.
go back to reference Melamed A, Cabili S, Zakuth V, Spirer Z (1988) The immune regulation in familial Mediterranean fever (FMF). J Clin Lab Immunol 26:125–128PubMed Melamed A, Cabili S, Zakuth V, Spirer Z (1988) The immune regulation in familial Mediterranean fever (FMF). J Clin Lab Immunol 26:125–128PubMed
15.
go back to reference Campen DH, Horwitz DA, Quismorio FP Jr, Ehresmann GR, Martin WJ (1988) Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 31:1358–1364PubMed Campen DH, Horwitz DA, Quismorio FP Jr, Ehresmann GR, Martin WJ (1988) Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 31:1358–1364PubMed
16.
go back to reference Wolf RE, Brelsford WG (1988) Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 31:729–735PubMed Wolf RE, Brelsford WG (1988) Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 31:729–735PubMed
17.
go back to reference Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA (1988) Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 31:844–849PubMed Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA (1988) Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 31:844–849PubMed
18.
go back to reference Rubin LA (1990) The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum 33:1145–1148PubMed Rubin LA (1990) The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum 33:1145–1148PubMed
19.
go back to reference Oppenheim JJ, Ruscetti FW, Faltynek C (1994) Cytokines. In: Stites P, Terr AI, Parslow TG (eds) Basic and clinical immunology, 8th edn. Appleton and Lange, Northwalk, pp 105–123 Oppenheim JJ, Ruscetti FW, Faltynek C (1994) Cytokines. In: Stites P, Terr AI, Parslow TG (eds) Basic and clinical immunology, 8th edn. Appleton and Lange, Northwalk, pp 105–123
20.
go back to reference Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118PubMed Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113–118PubMed
21.
go back to reference Drenth JPH, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JWM (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593PubMed Drenth JPH, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JWM (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593PubMed
22.
go back to reference Gang N, Drenth JPH, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JWM, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheum 26:890–897PubMed Gang N, Drenth JPH, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JWM, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheum 26:890–897PubMed
23.
go back to reference Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S (1988) Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 16:721–724 Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S (1988) Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 16:721–724
Metadata
Title
Continuity of cytokine activation in patients with familial Mediterranean fever
Authors
Sait Bagci
Bulent Toy
Ahmet Tuzun
Yuksel Ates
Murat Aslan
Ali Inal
Mustafa Gulsen
Necmettin Karaeren
Kemal Dagalp
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2004
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0925-4

Other articles of this Issue 4/2004

Clinical Rheumatology 4/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.